Gary Kelloff

Company: NIH

Job title: Special Advisor, DCTD, National Cancer Institute

Seminars:

Panel Discussion: Driving Widespread Adoption of Reproducible, Innovative & Clinically Validated LBx Tests to Improve Patient Access through Increased Reimbursements 9:15 am

What are the challenges faced in obtaining reimbursement for LBx tests? How to advise recommendations to improve reimbursement policies for LBx tests used in surveillance? What role does standardization, enhanced evidence generation, and ongoing communication/collaboration between stakeholders play in achieving reimbursements?Read more

day: Day Two

The Rise of Liquid Biopsy Assays & the Promise of Early Screening for Improved Patient Outcomes 8:30 am

The number of liquid biopsy assays are increasing as are the trials for their evaluation Assays have increasing sensitivity Early screening will result in better outcomes for cancer patientsRead more

day: Day One